Market News AIOpen the app

Alphatec Holdings shares what happened during their earnings call for the third quarter of 2026.

ResultsRead the original at Benzinga
Bad for ATEC

Alphatec grew sales and surgical use and generated positive cash, but sales missed expectations and it cut its 2026 sales and profit-margin forecasts. The cuts, tied to weak biologics sales and slower procedures, make the report negative for its outlook.

ATEC · Alphatec Holdings

AI read · Bad for ATEC

The AI's read

The cuts show that strong surgeon interest has not yet fixed weak biologics sales or slower spine procedures. Those problems could limit sales and profit margins beyond this quarter. Alphatec also grew surgical hardware sales and generated positive cash. Those gains help, but they did not stop the company from lowering both full-year forecasts.

Get alerts for ATEC

Follow Alphatec Holdings (ATEC) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for ATEC
Free on the App Store and Google Play, or on the web.